Anand Srivastava
Scientist-C
Animal Biotechnology
National Institute of Animal Biotechnology
India
Biography
Anand Srivastava is a Scientist-C in National institute of Animal Biotechnology. Education and training: Dr. Anand Srivastava completed B.Sc. (1999) from University of Delhi, Delhi, and M.Sc. (2001; Biotechnology) from the Allahabad University, Allahabad, India. He did Ph.D. (2008) from Jawaharlal University (JNU) working at International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India. He then worked at Institut Pasteur, Paris (2008-2011) and Institut National de Transfusion Sanguine, Paris (2011-2012) as a Post-doctoral Fellow. He joined National Institute of Animal Biotechnology (NIAB) in 2013. Research experience and interests: Dr. Srivastava has vast experience in parasite biology. He has worked intensively on malaria parasite where his research focus was understanding molecular host-parasite interaction(s). Presently he is working on a veterinary important parasite Theileria. His research interests are to understand the molecular basis of the disease Theileriosis. He is also interested in understanding the biology of the vector (tick) which transmits the Theileria parasite. Selected awards, honours and fellowships: Best Oral presentation award, 13th Conference on Vectors and Vector Borne Diseases, Chennai, 2017. Postdoctoral Fellowship, Fondation pour la Recherche Médicale (FRM), France (2011-2012). Keystone Symposia Scholarship, 2010. Fellowship to attend PHARE workshop, Martina Franca, Italy, 2009.
Research Interest
Dr. Srivastava has vast experience in parasite biology. He has worked intensively on malaria parasite where his research focus was understanding molecular host-parasite interaction(s). Presently he is working on a veterinary important parasite Theileria. His research interests are to understand the molecular basis of the disease Theileriosis. He is also interested in understanding the biology of the vector (tick) which transmits the Theileria parasite.
Publications
-
Dechavanne S, Srivastava A, Gangnard S, Nunes-silva S, Dechavanne C, Fievet N, Deloron P, Chêne A, Gamain B. 2015. The parity-dependent recognition of the DBL1X-3X suggests an important role of the VAR2CSA high affinity CSA-binding region in the development of the humoral response against placental malaria. Infection and Immunity 83(6):2466-74.
-
Gangnard S, Lewit-Bentley A, Dechavanne S, Srivastava A, Amirat F, Bentley GA, Gamain B. 2015. Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions. Scientific Reports 5:14868.
-
de Moraes LV, Dechavanne S, Sousa PM, Barateiro A, Cunha SF, Nunes-Silva S, Lima FA, Murillo O, Marinho CR, Gangnard S, Srivastava A, Braks JA, Janse CJ, Gamain B, Franke-Fayard B, Penha-Gonçalves C. 2016. A murine model for pre-clinical studies on Var2CSA-mediated pathology associated to malaria in pregnancy. Infection and Immunity 84: 1761-1764.